Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 5,698 | 3,828 | 3,188 | 2,379 | 508 |
| Gross Profit | 5,698 | 3,828 | 3,188 | 2,379 | 508 |
| Operating Expenses | 34,918 | 22,825 | 19,929 | 19,718 | 20,679 |
| Operating Income | -29,220 | -18,997 | -16,741 | -17,339 | -20,171 |
| Interest Expense | 541 | 493 | 487 | 271 | 0 |
| Other Income | -369 | 4 | 32 | 384 | 442 |
| Pre-tax Income | -30,130 | -19,486 | -17,196 | -17,226 | -19,729 |
| Net Income Continuous | -30,130 | -19,486 | -17,196 | -17,226 | -19,729 |
| Net Income | $-30,130 | $-19,486 | $-17,196 | $-17,226 | $-19,729 |
| EPS Basic Total Ops | -6.20 | -4.30 | -3.80 | -3.90 | -4.50 |
| EPS Basic Continuous Ops | -6.31 | -4.26 | -3.76 | -3.92 | -4.55 |
| EPS Diluted Total Ops | -6.20 | -4.30 | -3.80 | -3.90 | -4.50 |
| EPS Diluted Continuous Ops | -6.31 | -4.26 | -3.76 | -3.92 | -4.55 |
| EBITDA(a) | $-28,361 | $-18,151 | $-15,907 | $-16,556 | $-19,273 |